Dr. Kazandjian is a hematologic oncologist and clinician-scientist whose clinical research focuses on multiple myeloma and its precursor plasma cell dyscrasias (monoclonal gammopathy of unknown significance (MGUS) and smoldering myeloma).Dr. Kazandjian has a particularly strong interest in identifying high-risk smoldering myeloma patients who may benefit from early treatment strategies and the dev… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Boston University School of Medicine | Doctorate | Other | 2003 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Wilford Hall Medical Center, USAF | Internal Medicine | 2006 |
| Fellowship - National Institutes of Health Clinical Center | Hematology/Oncology | 2012 |
| Certification | Cert. Body | Year |
|---|---|---|
| Internal medicine | Internal Medicine | Not Specified |
Accepts New Patients: Yes
Dickran Kazandjian, MD has not yet listed the medications that he commonly prescribes.
Dickran Kazandjian, MD has not yet specified the insurance plans he accepts.
